GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WAVE Life Sciences Ltd (STU:1U5) » Definitions » ROE % Adjusted to Book Value

WAVE Life Sciences (STU:1U5) ROE % Adjusted to Book Value : 7.31% (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is WAVE Life Sciences ROE % Adjusted to Book Value?

WAVE Life Sciences's ROE % for the quarter that ended in Dec. 2024 was 68.20%. WAVE Life Sciences's PB Ratio for the quarter that ended in Dec. 2024 was 9.33. WAVE Life Sciences's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 7.31%.

WAVE Life Sciences ROE % Adjusted to Book Value Historical Data

The historical data trend for WAVE Life Sciences's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WAVE Life Sciences ROE % Adjusted to Book Value Chart

WAVE Life Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -42.82 -40.27 - - -8.40

WAVE Life Sciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -13.51 - -42.17 7.31

Competitive Comparison of WAVE Life Sciences's ROE % Adjusted to Book Value

For the Biotechnology subindustry, WAVE Life Sciences's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WAVE Life Sciences's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, WAVE Life Sciences's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where WAVE Life Sciences's ROE % Adjusted to Book Value falls into.


;
;

WAVE Life Sciences ROE % Adjusted to Book Value Calculation

WAVE Life Sciences's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-78.37% / 9.33
=-8.40%

WAVE Life Sciences's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=68.20% / 9.33
=7.31%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WAVE Life Sciences ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of WAVE Life Sciences's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

WAVE Life Sciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WAVE Life Sciences Ltd (STU:1U5) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
CLDX DYN LQDA SPRY OCUL ETNB VRDN ARDX IOVA IDYA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
WVE:USA 1U5:Germany
Address
7 Straits View No. 12-00, Marina One East Tower, Singapore, SGP, 018936
Website
https://www.wavelifesciences.com
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

WAVE Life Sciences Headlines

No Headlines